ArticleBioresources and bioprocessing2025
Lactobacillus plantarum ferment of forsythia suspensa mitigates UVB-induced photoaging in HaCaT keratinocytes by modulating the metabolite profile and enhancing anti-photoaging activities.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The aqueous extract and Lactobacillus plantarum fermentation broth were prepared from forsythia as plant raw material, and the two extracts were investigated for the evaluation of cosmetic efficacy in antioxidant, anti-inflammatory repair, and safety after the establishment of the UVB damage HaCaT cell model. The results showed that the forsythia fermentation broth and the aqueous extract had good scavenging activities against DPPH radicals, hydroxyl radicals, ABTS radicals and reactive oxygen species, and the fermentation broth had significantly stronger antioxidant effects than the aqueous extract. At the level of protein expression and gene transcription, the forsythia fermentation broth reduced the content of inflammatory factors (TNF-α, IL-8, IL-6, IL-1β) and apoptotic factors (Caspase-3, Caspase-9, Bax, Bcl-2) in the cells and even tended to the normal level, and the effect was higher than that of aqueous solution as the blank control, which indicated that the forsythia fermentation broth had anti-inflammatory and restorative effects. Full metabolite profiling by chromatographic tandem mass spectrometry (HPLC-MS/MS) of the aqueous extract and forsythia fermentation broth revealed that the fermentation broth modulated the metabolite profile. This modulation was associated with significantly enhanced protective effects, as evidenced by boosted oxidative stress and anti-inflammatory responses at the cellular level against UVB-induced HaCaT cells. Using chicken embryo allantoic membrane eye irritation experiment and erythrocyte haemolysis experiment on the aqueous extract and forsythia fermentation broth for safety evaluation experiments, the irritation scores were 0.09, 0.08, respectively, and there was no haemolysis of blood vessels, which indicated that the aqueous extract of forsythia and the fermentation solution did not have eye irritation, and that the use of forsythia fermentation broth in a safe range had no detrimental effect on cell membranes and was not irritating.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.